The stock of Cigna Group (CI) has seen a 0.59% increase in the past week, with a -7.73% drop in the past month, and a 3.62% flourish in the past quarter. The volatility ratio for the week is 2.78%, and the volatility levels for the past 30 days are at 2.45% for CI. The simple moving average for the past 20 days is -4.57% for CI’s stock, with a -3.25% simple moving average for the past 200 days.
Is It Worth Investing in Cigna Group (NYSE: CI) Right Now?
Cigna Group (NYSE: CI) has a price-to-earnings ratio that is above its average at 17.21x. The stock has a 36-month beta value of 0.46. Opinions on the stock are mixed, with 13 analysts rating it as a “buy,” 6 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for CI is 262.90M, and at present, short sellers hold a 1.34% of that float. On May 22, 2025, the average trading volume of CI was 1.84M shares.
CI) stock’s latest price update
The stock of Cigna Group (NYSE: CI) has decreased by -2.02 when compared to last closing price of 317.09.Despite this, the company has seen a gain of 0.59% in its stock price over the last five trading days. reuters.com reported 2025-05-21 that Cigna said on Wednesday it was launching an add-on to pharmacy benefit management plans in which patients could pay no more than $200 a month out-of-pocket for weight-loss drugs Wegovy and Zepbound.
Analysts’ Opinion of CI
Many brokerage firms have already submitted their reports for CI stocks, with Bernstein repeating the rating for CI by listing it as a “Mkt Perform.” The predicted price for CI in the upcoming period, according to Bernstein is $323 based on the research report published on February 06, 2025 of the current year 2025.
Piper Sandler, on the other hand, stated in their research note that they expect to see CI reach a price target of $400. The rating they have provided for CI stocks is “Overweight” according to the report published on June 26th, 2024.
Robert W. Baird gave a rating of “Outperform” to CI, setting the target price at $388 in the report published on May 30th of the previous year.
CI Trading at -4.43% from the 50-Day Moving Average
After a stumble in the market that brought CI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.22% of loss for the given period.
Volatility was left at 2.45%, however, over the last 30 days, the volatility rate increased by 2.78%, as shares sank -7.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.16% upper at present.
During the last 5 trading sessions, CI rose by +0.87%, which changed the moving average for the period of 200-days by -4.35% in comparison to the 20-day moving average, which settled at $325.58. In addition, Cigna Group saw 12.50% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CI starting from Palmer Eric P, who proposed sale 610 shares at the price of $335.08 back on May 09 ’25. After this action, Palmer Eric P now owns shares of Cigna Group, valued at $204,399 using the latest closing price.
Palmer Eric P, the Former Officer of Cigna Group, proposed sale 14,985 shares at $335.61 during a trade that took place back on May 08 ’25, which means that Palmer Eric P is holding shares at $5,029,097 based on the most recent closing price.
Stock Fundamentals for CI
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 1.0 for the gross margin
The net margin for Cigna Group stands at 0.02. The total capital return value is set at 0.07. Equity return is now at value 12.37, with 3.42 for asset returns.
Based on Cigna Group (CI), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 0.76. The interest coverage ratio of the stock is 4.64.
Currently, EBITDA for the company is 9.48 billion with net debt to EBITDA at 2.01. When we switch over and look at the enterprise to sales, we see a ratio of 0.41. The receivables turnover for the company is 9.45for trailing twelve months and the total asset turnover is 1.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.78.
Conclusion
To sum up, Cigna Group (CI) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
